Outcomes of adults who received liver transplant as young children.
ALP, alkaline phosphatase
AST, aspartate aminotransferase
BA, biliary atresia
BMI, body mass index
GGT, gamma-glutamyl transferase
IMPARTS, Integrating Mental and Physical Healthcare: Research, Training and Services
IQR, interquartile range
Liver transplantation
SD, standard deviation
biopsychosocial
eGFR, estimated glomerular filtration rate
long-term
outcomes
pLT, pediatric liver transplantation
pediatric
Journal
EClinicalMedicine
ISSN: 2589-5370
Titre abrégé: EClinicalMedicine
Pays: England
ID NLM: 101733727
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
12
04
2021
revised:
06
06
2021
accepted:
10
06
2021
entrez:
10
9
2021
pubmed:
11
9
2021
medline:
11
9
2021
Statut:
epublish
Résumé
Patient and graft survival 20-years after pediatric liver transplantation (pLT) are excellent. In children, attainment of normal growth, education and social adaptation to be an independent adult are equally important. This is particularly relevant for children who receive liver transplant at a young age, where infantile-onset liver disease, surgery and immunosuppression can adversely affect growth and neurodevelopment. The aim of this study was to evaluate the long-term physical and psychosocial outcomes of pLT recipients with normal graft function. We coin the term 'meaningful survival'. We performed a cross-sectional study of pLT recipients who received transplants between 1985 and 2004. A 20-year evaluation of physical health (growth, renal function), mental wellbeing and social outcomes (substance abuse, adherence, education, employment) was performed. All patients included were considered to have normal graft function. Eighty-four patients met study criteria. Median age at transplantation was 1.3 years (IQR 0·7-3·3 years), with median duration of follow-up of 20.2 years (18·0-23·5). At median of 20-years, 19 patients (23%) had chronic renal dysfunction and 3 patients (4%) had a BMI of >30 (mean 20·4). Evaluation of long-term psychosocial outcomes demonstrated 22 patients (26%) with mental health disorders. Substance abuse was lower than national average. 62 patients (74%) were in education, employment or training. Overall, only 26% of our cohort achieved a composite outcome of 'meaningful survival'. This is the largest reported long-term study of biopsychosocial outcomes of pLT recipients with normal liver biochemistry, with follow-up upon completion of physical growth and senior school education. Importantly, despite normal liver function, many patients did not demonstrate 'meaningful survival'. We must refocus our efforts towards better understanding the long-term outcomes of children. A 'meaningful survival' rather than mere survival should be our goal. None.
Sections du résumé
BACKGROUND
BACKGROUND
Patient and graft survival 20-years after pediatric liver transplantation (pLT) are excellent. In children, attainment of normal growth, education and social adaptation to be an independent adult are equally important. This is particularly relevant for children who receive liver transplant at a young age, where infantile-onset liver disease, surgery and immunosuppression can adversely affect growth and neurodevelopment. The aim of this study was to evaluate the long-term physical and psychosocial outcomes of pLT recipients with normal graft function. We coin the term 'meaningful survival'.
METHODS
METHODS
We performed a cross-sectional study of pLT recipients who received transplants between 1985 and 2004. A 20-year evaluation of physical health (growth, renal function), mental wellbeing and social outcomes (substance abuse, adherence, education, employment) was performed. All patients included were considered to have normal graft function.
FINDINGS
RESULTS
Eighty-four patients met study criteria. Median age at transplantation was 1.3 years (IQR 0·7-3·3 years), with median duration of follow-up of 20.2 years (18·0-23·5). At median of 20-years, 19 patients (23%) had chronic renal dysfunction and 3 patients (4%) had a BMI of >30 (mean 20·4). Evaluation of long-term psychosocial outcomes demonstrated 22 patients (26%) with mental health disorders. Substance abuse was lower than national average. 62 patients (74%) were in education, employment or training. Overall, only 26% of our cohort achieved a composite outcome of 'meaningful survival'.
INTERPRETATION
CONCLUSIONS
This is the largest reported long-term study of biopsychosocial outcomes of pLT recipients with normal liver biochemistry, with follow-up upon completion of physical growth and senior school education. Importantly, despite normal liver function, many patients did not demonstrate 'meaningful survival'. We must refocus our efforts towards better understanding the long-term outcomes of children. A 'meaningful survival' rather than mere survival should be our goal.
FUNDING
BACKGROUND
None.
Identifiants
pubmed: 34505022
doi: 10.1016/j.eclinm.2021.100987
pii: S2589-5370(21)00267-4
pmc: PMC8413260
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100987Informations de copyright
© 2021 The Authors.
Références
Transplant Proc. 1987 Aug;19(4):3267-76
pubmed: 3303493
J Pediatr. 1989 Apr;114(4 Pt 1):574-81
pubmed: 2647947
J Am Coll Surg. 2007 May;204(5):904-14; discussion 914-6
pubmed: 17481508
J R Soc Med. 1991 Sep;84(9):550-3
pubmed: 1719199
Am J Transplant. 2012 Jun;12(6):1486-95
pubmed: 22568621
Lancet. 2020 Jan 18;395(10219):226-239
pubmed: 31791690
Arch Dis Child. 1990 Sep;65(9):1000-3
pubmed: 2121105
J Pediatr. 2010 Jun;156(6):936-940.e1
pubmed: 20223479
Transplantation. 2008 Oct 27;86(8):1028-34
pubmed: 18946339
Liver Transpl. 2010 Sep;16(9):1041-8
pubmed: 20818741
Am J Transplant. 2018 Jul;18(7):1680-1689
pubmed: 29247469
Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2760-73
pubmed: 24096190
J Pediatr. 2012 May;160(5):820-6.e3
pubmed: 22192813
Liver Transpl. 2005 Mar;11(3):344-9
pubmed: 15719405
Pediatr Gastroenterol Hepatol Nutr. 2013 Dec;16(4):207-18
pubmed: 24511516
Pediatr Clin North Am. 2010 Apr;57(2):539-57, table of contents
pubmed: 20371051
Transplantation. 2011 May 15;91(9):1025-30
pubmed: 21378604
Liver Transpl. 2016 Apr;22(4):495-504
pubmed: 26850789
Liver Transpl. 2016 Nov;22(11):1544-1553
pubmed: 27597423
Transplantation. 2006 Mar 15;81(5):672-7
pubmed: 16534467
Pediatr Transplant. 2009 Feb;13(1):111-8
pubmed: 18093086
BMC Public Health. 2018 Oct 10;18(1):1090
pubmed: 30301472
Surg Gynecol Obstet. 1963 Dec;117:659-76
pubmed: 14100514
Ann Transplant. 2009 Jul-Sep;14(3):45-50
pubmed: 19644159
Liver Transpl. 2012 Nov;18(11):1290-301
pubmed: 22847917
Pediatr Transplant. 2009 Feb;13(1):96-103
pubmed: 18673354
Am J Transplant. 2018 Sep;18(9):2229-2237
pubmed: 29745028
Liver Transpl. 2017 Mar;23(3):361-374
pubmed: 28006876
Ann Surg. 2010 Oct;252(4):652-61
pubmed: 20881772